RESMED INC — Director's Dealing 2019

Feb 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-02-11

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-11	ResMed Common Stock	M	2517	$43.63	Acquired	288799	Direct
2019-02-11	ResMed Common Stock	S	2517	$97.107	Disposed	286282	Direct
2019-02-11	ResMed Common Stock	M	4134	$43.63	Acquired	290416	Direct
2019-02-11	ResMed Common Stock	S	4134	$97.221	Disposed	286282	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-11	ResMed Common Stock Options	$43.63	M	2517	Disposed	2020-03-01	ResMed Commmon Stock (2517)	Direct
2019-02-11	ResMed Common Stock Options	$43.63	M	4134	Disposed	2020-03-01	ResMed Commmon Stock (4134)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	10340	Indirect

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: This transaction was executed in multiple trades at prices ranging from $96.84 to $97.52. The price reported above reflects the weighted average sale price.

F3: This transaction was executed in multiple trades at prices ranging from $97.05 to $97.41. The price reported above reflects the weighted average sale price.

F4: Represents date options first become exercisable. Options vest 1/3 annually.